Additionally, it addresses the FDA’s communications Along with the applicant, the retention of records that assist the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may transfer ownership of an SE report to a whole new applicant and electronic submission with the SE report and a